Bruker Corporation (Nasdaq: BRKR) this week displays its
high-value scientific instrumentation, software and integrated
solutions for applications in materials and energy research,
biopharmaceuticals, applied markets, as well as life science and
translational research at Analytica 2022.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20220621005512/en/
HYPERION II FT-IR / IR Laser Imaging
Microscope (Photo: Business Wire)
Frank H. Laukien, PhD, President and CEO of Bruker Corporation,
commented: “Our differentiated high-value scientific instruments
and solutions shown at Analytica 2022 demonstrate the diversity,
flexibility and high performance that Bruker brings to the world of
laboratory science. Bruker is committed to providing optimized
technological, software, chemistry and biology solutions to enable
the success of our customers. We are very pleased to introduce
novel solutions that now also enable Spatial Single-Cell
Metabolomics, a key new capability for in situ, multiomics
single-cell biology and cancer research.”
Applied & Industrial Markets
Bruker launches the HYPERION II FT-IR / IR Laser Imaging
Microscope as a flexible research platform, combining FT-IR
microscopy with QCL IR laser imaging. The HYPERION II is the
first IR laser microscope that provides all three transmission,
reflection, and ATR modes. Intuitive software allows seamless
switching between FT-IR and QCL technology. With an unprecedented
imaging speed of 6 mm² per second it sets the new benchmark in
vibrational microscopy.
The new TGA II FT-IR module enables advanced gas analysis
by hyphenation of thermogravimetry (TG) and FT-IR spectroscopy. Its
new cell design allows high temperature analysis up to 370° C. Most
applications can now be covered with a DTGS detector without the
need for liquid Nitrogen. The TGA II is prepared for
adaption to TG balances from partner Netzsch, and other
manufacturers.
Bruker introduces PoN mass spectrometry for accelerated
measurements without chromatography to bring the power of mass
spectrometry (MS) to new food, beverage, forensics, industrial,
security, environmental and pharmaceutical applications. The new
Point of Need (PoN) DART-EVOQ triple quadrupole MS system
has been developed with the IonSense DART source to enable PoN
workflows that reduce analysis time to seconds or minutes, with
little to no preparation for rapid analyses of solid, liquid or gas
samples.
Food Analysis Solutions
Bruker releases the MPA II Dairy Analyzer for a new
standard in quality control and analysis of liquid and solid
samples in the dairy industry, and also for plant-based
alternatives. It allows automated sampling and homogenization for
analyzing liquid products, or with an integrating sphere can also
measure heterogeneous materials without sample preparation in
diffuse reflection. Near-infrared (NIR) spectroscopy is an
acknowledged method for liquid and solid sample types, described in
the ISO 21543 | IDF 201 guidelines released in 2020.
A new NMR Olive Oil-Profiling 1.0™ solution delivers
authenticity and quality analysis of olive oil, one of the most
adulterated food products worldwide. Olive Oil-Profiling 1.0
is available on the benchtop Fourier™ 80 system for olive oil
bottlers, as well as on the 400 MHz NMR FoodScreener™ platform for
advanced testing laboratories.
Novel Laboratory Solutions for BioPharma
Bruker showcases new Fourier 80 FT-NMR capabilities for
pharmaceutical and chemical analysis. The Fourier 80
benchtop spectrometer does not require special lab infrastructure
or cryogens and offers excellent 1H sensitivity of 200:1 for
gradient spectroscopy proton probes, bringing FT-NMR to more
research and analytical laboratories. The new Fourier 80
Adjustable Temperature (AT) option enables analysis up to 60°C, and
the AT option is compatible with the Fourier 80 PAL sample changer
option.
A new benchtop FT-NMR Reaction Monitoring solution and
GxP Readiness Kit for the Fourier 80 reaction monitoring
solution RxnLab™ has been introduced for chemical and
pharmaceutical labs, and features temperature-controlled reaction
paths for optimizing process control and monitoring reaction
products with the new Fourier 80 flow accessory. Running
InsightMR software, the RxnLab brings benchtop FT-NMR to bio- and
chemical production for non-NMR experts. The new Fourier 80 GxP
Readiness Kit allows full GxP compliance for development and
manufacturing labs with 21 CFR part 11 compliance.
The integration of the timsTOF flex platform with 5
micrometer single-cell resolution and novel MALDI Hiplex-IHC
assays ushers in the era of unbiased Spatial Single-Cell
Metabolomics (SSCM) and enables in situ multiomics tissue and
single cell biology research to accelerate drug development.
Bruker’s strategic partnership with AmberGen brings game-changing
capabilities to single-cell biology with spatial multiomics
capabilities that allow researchers to simultaneously observe how
drugs affect both protein and metabolic states by combining
targeted, high-plex MALDI HiPLEX-IHC protein spatial
profiling with unbiased, cellular-resolution, small-molecule MALDI
Imaging for co-localization of proteins, and of small molecules
such as glycans, lipids, metabolites, or xenobiotics.
Microscopy and Nanoanalysis
The new NeuraLight 3D Ultra™ module expands neuroscience
research capabilities and optogenetics applications on Bruker’s
Ultima multiphoton microscopes. NeuraLight 3D Ultra provides
revolutionary 3D holographic photostimulation, optimized for
functional and large-scale studies of neural networks and brain
computation. Building upon proprietary spatial light modulator
(SLM) technology, NeuraLight 3D Ultra utilizes a new, larger liquid
crystal chip for a larger field of view, improved targeting
precision, and market-leading speed of 600 hologram frames per
second.
Bruker introduces XFlash® 7, the next generation of EDS
detectors for elemental analysis with QUANTAX™ energy dispersive
X-ray spectrometer (EDS) accessories that enable chemical analysis
on electron microscopes with ultimate speed, sensitivity, and
reliability. The new and unique features of XFlash 7 for further
increase performance, productivity and lowers the cost of
ownership. XFlash 7 detectors offer a range of detector sizes,
shapes and window materials, and are designed to provide maximum
collection angles for X-rays, with optimized ratio of active
detector area and sample-detector distance.
Translational and Clinical Proteomics Research
The new timsTOF® HT features a 4th-generation TIMS-XR
(trapped ion mobility separation) cell and 14-bit digitizer for
even greater dynamic range in proteomics, enhanced peptide coverage
and more accurate quantitation, particularly in unbiased 4D plasma
and tissue proteomics and epiproteomics. dia-PASEF acquisition on
the timsTOF HT quantifies proteins across a large dynamic range
even in difficult samples, such as cardiac tissue, without
sacrificing throughput or sensitivity.
For more information, visit bruker.com and our Bruker booth
#A2.314 at Analytica.
About Bruker Corporation (Nasdaq: BRKR)
Bruker is enabling scientists to make breakthrough discoveries
and develop new applications that improve the quality of human
life. Bruker’s high performance scientific instruments and high
value analytical and diagnostic solutions enable scientists to
explore life and materials at molecular, cellular and microscopic
levels. In close cooperation with our customers, Bruker is enabling
innovation, improved productivity and customer success in life
science molecular and cell biology research, in applied and pharma
applications, in microscopy and nanoanalysis, as well as in
industrial applications. Bruker offers differentiated, high-value
life science and diagnostics systems and solutions in preclinical
imaging, clinical phenomics research, proteomics and multiomics,
spatial and single-cell biology, functional structural and
condensate biology, as well as in clinical microbiology and
molecular diagnostics. For more information, please visit:
www.bruker.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220621005512/en/
Investor: Justin Ward Senior Director of Investor
Relations & Corporate Development T: +1 (978) 663-3660, ext.
1479 E: Investor.relations@bruker.com
Media: Thorsten Thiel, Ph.D. VP of Group Marketing Bruker
BioSpin T: +49 (721) 5161–6500 E: pr@bruker.com
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jul 2023 to Jul 2024